Keyphrases
Humoral Immune Response
100%
Prostate Cancer Progression
100%
Human Endogenous Retrovirus
100%
HERV-K
100%
Prostate Cancer
33%
Androgens
22%
Patients with Prostate Cancer
22%
Autoantibodies
22%
Biochemical Recurrence
22%
Advanced Prostate Cancer
22%
Demethylation
22%
Patient Survival
11%
Malignant Cells
11%
Healthy Donors
11%
Autoimmune Disease
11%
Cancer Antigen
11%
Serum Antibody
11%
Recurrence Rate
11%
Bona Fide
11%
Clinical Course
11%
In Vitro Expression
11%
Immunogenicity
11%
Human Genome
11%
Cancer Tissue
11%
Tissue Cells
11%
Patient Serum
11%
Stage III-IV
11%
Promoter Region
11%
Self-antigens
11%
Serological Screening
11%
Tissue Microarray
11%
Protein Array
11%
Prostate Tissue
11%
Cell Effects
11%
Malignant Tissue
11%
Neoplastic Disease
11%
Seroreactivity
11%
Array Profiling
11%
Early Prostate Cancer
11%
Seromics
11%
Immunology and Microbiology
Endogenous Retrovirus
100%
Humoral Immunity
100%
Autoantibodies
18%
Prostate
18%
Demethylation
18%
Autoimmunity
9%
Promoter Region
9%
Tumor Antigen
9%
Antibody Blood Level
9%
Cell Line
9%
ELISA
9%
Immunogenicity
9%
Cancer Tissue
9%
Human Genome
9%
Prostate Tissue
9%
In Vitro
9%
Biochemistry, Genetics and Molecular Biology
Endogenous Retrovirus
100%
Humoral Immunity
100%
Demethylation
18%
Autoantibodies
18%
Promoter Region
9%
Autoimmunity
9%
Tumor Antigen
9%
Antibody Blood Level
9%
Human Genome
9%
Immunogenicity
9%
Tissue Microarray
9%
Protein Microarray
9%